Ciprofloxacin in the treatment of malignant external otitis.

Abstract:

:Malignant external otitis is a serious infection most frequently caused by Pseudomonas aeruginosa. Because of its antipseudomonal activity and good tissue penetration, ciprofloxacin is an antibiotic which should, in theory, be effective in the treatment of this type of infection. Publications on the use of ciprofloxacin in the treatment of malignant external otitis are analysed below. This paper analyses 84 clinical case studies collected from 13 publications: ciprofloxacin, administered for the most part orally, was given in a dosage of 750 mg twice daily, apart from three studies where a lower dosage of 500 mg twice daily was used. When the drug was administered parenterally, the dosage was 200 mg b.i.d. In one publication, ciprofloxacin was used in combination with rifampicin. The average duration of treatment was 3 months. Ps. aeruginosa was isolated in 82 patients and sensitivity tests were carried out on 47 strains, none of which was resistant to ciprofloxacin. The clinical cure rate was 96.4% (84 patients). The rate of bacteriological eradication was close to 100% in the 76 evaluable patients. Long-term follow-up (between 2 and 44 months) showed that clinical and bacteriological cure was maintained in all but two patients. Ciprofloxacin thus seems to be a particularly useful antibiotic for the treatment of malignant external otitis, both because of its clinical and bacteriological efficacy and because it is well tolerated.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Gehanno P

doi

10.1159/000239315

subject

Has Abstract

pub_date

1994-01-01 00:00:00

pages

35-40

eissn

0009-3157

issn

1421-9794

journal_volume

40 Suppl 1

pub_type

杂志文章,评审
  • Renal sparing by amphotericin B colloidal dispersion: clinical experience in 572 patients.

    abstract::Data from five clinical trials of amphotericin B colloidal dispersion (ABCD) in the treatment of invasive mycoses were pooled to analyze the renal sparing effects of ABCD. Serum creatinine levels at baseline and either during or at end of treatment were available for 499 of 572 patients (87.2%). The median cumulative ...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000048469

    authors: Gurwith M,Mamelok R,Pietrelli L,Du Mond C

    更新日期:1999-06-01 00:00:00

  • Biliary excretion of tetroxoprim in man.

    abstract::The biliary excretion of tetroxoprim (TXP) was studied in 10 patients with T-tube drainage. A mean biliary peak of 32.56 +/- 7.69 micrograms/ml was observed 2-3 h after a single oral dose of 200 mg. The biliary elimination rate constant (kb) of TXP was found to be 0;056 (h-1), indicating a longer elimination from the ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238097

    authors: Vergin H,Luber P

    更新日期:1982-01-01 00:00:00

  • Comparative antibacterial activity of the penem ALP 201.

    abstract::The minimum inhibitory concentration (MIC) of the new penem ALP 201 was tested against 243 recent clinical isolates of which 95 were from the family Enterobacteriaceae, 50 were from the genus Streptococcus, 50 were Staphylococcus aureus and 48 were Staphylococcus epidermidis. An agar dilution technique was used to det...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238888

    authors: Bergan T,da Fonseca J

    更新日期:1991-01-01 00:00:00

  • Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.

    abstract::The pharmacokinetics of ceftriaxone (CRO) after subcutaneous and intravenous administration was studied in 10 healthy volunteers (5 males, 5 females, age 22-43 years, body weight 64.3 +/- 9.5 kg). Each of them received 2.0 g CRO i.v., and then 0.5 g i.v. and 0.5 g CRO s.c. in a randomized cross-over design. Subcutaneo...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238342

    authors: Borner K,Lode H,Hampel B,Pfeuffer M,Koeppe P

    更新日期:1985-01-01 00:00:00

  • Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.

    abstract::Ciprofloxacin (CIP) and metabolite concentrations in lung tissue, parietal pleura and bronchial tissue were assessed in 43 adult patients who underwent lung surgery. A single oral dose of CIP was given for prophylaxis of bacterial infections. Two to 6 h prior to tissues sampling, 23 patients received 250 mg and 20 sub...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238860

    authors: Rohwedder R,Bergan T,Caruso E,Thorsteinsson SB,Della Torre H,Scholl H

    更新日期:1991-01-01 00:00:00

  • Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.

    abstract:BACKGROUND:The collagen gel droplet embedded drug sensitivity test (CD-DST) is a new anticancer drug sensitivity test that only requires a small number of cells. We report the use of this test in the choice of adjuvant chemotherapy for treatment of a rare case of ovarian cancer involving malignant transformation of ova...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000099985

    authors: Yamagami W,Banno K,Kawaguchi M,Yanokura M,Kuwabara Y,Hirao N,Susumu N,Tsukazaki K,Aoki D

    更新日期:2007-01-01 00:00:00

  • Antibacterial effects of meropenem and imipenem against Haemophilus influenzae.

    abstract::Phase contrast microscopy, killing curves and turbidimetric growth curves were used in a comparative study of the antibacterial effects of imipenem and meropenem on Haemophilus influenzae. The minimal inhibitory concentrations (MICs) and their ranges of meropenem and imipenem using five beta-lactamase-producing strain...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238830

    authors: Yourassowsky E,Van der Linden MP,Crokaert F

    更新日期:1991-01-01 00:00:00

  • Outer membrane proteins and elastase of Pseudomonas aeruginosa after the postantibiotic effect induced by amikacin.

    abstract::Postantibiotic effects were induced in three Pseudomonas aeruginosa strains after short-term treatment (30 min) with amikacin at suprainhibitory concentrations in the range of 0.6-1.2 h (2 x MIC) and of 3.0-4.4 h (4 x MIC). Significant suppression of P. aeruginosa elastase activity was found after treatment with amika...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239545

    authors: Hostacká A,Karelová E

    更新日期:1997-03-01 00:00:00

  • Response profiles: A method of evaluating the activity of beta-lactam antibiotics against Enterobacteria.

    abstract::A method is described which may be used to compare the relative activity of beta-lactam antibiotics against gram-negative bacilli. The method offers several important advantages over conventional methods of evaluation of the antibacterial activity of beta-lactam agents: the bacterial inoculum is simply and accurately ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221965

    authors: Greenwood D

    更新日期:1977-01-01 00:00:00

  • Mammary tumor and melanoma cell transport of PTT.119, a bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids.

    abstract::Uptake of the bifunctional alkylating agent, PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy-HCl, by the MJY-alpha mammary tumor and B16 melanoma cell lines occurred via two natural pathways for amino acid transport. The primary route of PTT.119 entry was the classical L System, whereas, the ASC System ca...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238549

    authors: Yagi MJ,Scanlon KJ,Chin SE,Bekesi JG

    更新日期:1988-01-01 00:00:00

  • Susceptibility of Campylobacter pylori isolated from pediatric and adult patients to seven new quinolone antibiotics and nalidixic acid.

    abstract::The susceptibility of 26 strains of Campylobacter pylori to 7 new quinolone antibiotics and nalidixic acid was determined. All strains were resistant to nalidixic acid. Difloxacin, A-56620, A-62254, and ciprofloxacin were equally effective against the test strains with MICs ranging from 0.06 to 2.0 micrograms/ml. Fler...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238589

    authors: Hupertz V,Carr H,Czinn SJ

    更新日期:1988-01-01 00:00:00

  • Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.

    abstract::The aim of this research was to collect precise data on the antibacterial activity of ceftriaxone and cefotaxime in the respiratory tract. The diffusion into pulmonary tissue and bronchial secretion and the antibacterial activity of the two antibiotics were evaluated in vivo by means of the inhibitory quotient. Ceftri...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238651

    authors: Fraschini F,Scaglione F

    更新日期:1989-01-01 00:00:00

  • Effectiveness and Safety of Combination Therapy of Transarterial Chemoembolization and Apatinib for Unresectable Hepatocellular Carcinoma in the Chinese Population: A Meta-Analysis.

    abstract:BACKGROUND:The combination of transarterial chemoembolization (TACE) and apatinib has been used in the treatment of intermediate or advanced hepatocellular carcinoma (HCC). However, its effectiveness and safety are also argued. METHODS:Eligible studies were collected from a computer search of literatures published fro...

    journal_title:Chemotherapy

    pub_type: 杂志文章,meta分析,评审

    doi:10.1159/000502510

    authors: Wei Y,Liu J,Yan M,Zhao S,Long Y,Zhang W

    更新日期:2019-01-01 00:00:00

  • Clinical efficacy of perioperative antimicrobial prophylaxis in neurosurgery--a prospective randomized study involving 159 patients.

    abstract::In a randomized study 87 patients received perioperative antibiotic prophylaxis with 2 x 2 g ceftriaxone (Rocephin) at the beginning of the operation and in the following morning. Seventy-two patients received no antibiotic prophylaxis. In patients receiving the prophylaxis, a lower incidence of infections was observe...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238686

    authors: Winkler D,Rehn H,Freckmann N,Nowak G,Herrmann HD

    更新日期:1989-01-01 00:00:00

  • Antineoplastic strategy: irreversible tumor blood flow stasis induced by the combretastatin A-4 derivative AVE8062 (AC7700).

    abstract::Despite extensive research efforts, effective therapies for refractive cancers have not yet been established, and development of successful treatment strategies remains the most important task in the field of oncology. We recently showed that AVE8062 (formerly AC7700), a derivative of combretastatin A-4, achieved irre...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000088961

    authors: Hori K

    更新日期:2005-10-01 00:00:00

  • Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors.

    abstract::Cardiovascular (CV) adverse events are considered common complications of ponatinib treatment. Recently, it has been demonstrated that ponatinib dose reductions in definite settings can obtain optimal responses and lower ponatinib-related CV events. In this study, we describe the management of 5 patients with chronic ...

    journal_title:Chemotherapy

    pub_type:

    doi:10.1159/000504664

    authors: Santoro M,Accurso V,Mancuso S,Contrino AD,Sardo M,Novo G,Di Piazza F,Perez A,Russo A,Siragusa S

    更新日期:2019-01-01 00:00:00

  • Effect of probenecid on the pharmacokinetics of DQ-2556, a new 3-quaternary ammonium cephalosporin antibiotic, in humans.

    abstract::A total of 5 healthy volunteers were enrolled in a crossover study on the dose dependency and the effect of probenecid on pharmacokinetics of DQ-2556. They were administered intravenously 0.5 and 1.0 g of DQ-2556, and 1.0 g of DQ-2556 with oral administration of probenecid. The linearity in pharmacokinetics of DQ-2556...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239029

    authors: Shiba K,Yoshida M,Shimada J,Saito A,Matsubayashi K,Hashimoto S,Yoshida K,Osada Y,Sakai O

    更新日期:1992-01-01 00:00:00

  • Ofloxacin, a bactericidal antibacterial.

    abstract::Ofloxacin, like other 4-quinolones, is unusual among front line drugs available to treat bacterial infections since it affects bacterial DNA synthesis, rather than cell wall or protein synthesis. The 4-quinolones are also unusual because even for serious infections they can be given orally. Most unusually transferable...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000238899

    authors: Smith JT

    更新日期:1991-01-01 00:00:00

  • In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients.

    abstract::Owing to the predominance of gram-positive pathogens in neutropenic cancer patients, newer generation quinolones with an expanded gram-positive spectrum and enhanced potency, may have a role to play for prophylaxis and/or empiric therapy in such patients. The in vitro activity of gatifloxacin was compared with that of...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000081708

    authors: Rolston KV,Vaziri I,Frisbee-Hume S,Streeter H,LeBlanc B

    更新日期:2004-11-01 00:00:00

  • Rifampicin in free combination with other antimicrobial drugs in non-Tb infections. Clinical data on 650 patients (a review).

    abstract::A review of the published literature has allowed the identification of a number of non-tubercular indications where rifampicin (trade mark Ciba-Geigy: Rimactane) has been successfully used in combination with other chemotherapeutic agents. The cases reviewed with regard to effectiveness sum 562. The most frequently co...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000238006

    authors: Kissling M,Bergamini N

    更新日期:1981-01-01 00:00:00

  • A 13-year study of antimicrobial susceptibility of common gram-negative bacteria isolated from the bloodstream in a teaching hospital.

    abstract::The choice of antimicrobial therapy for the treatment of bacteremia is often empirical and based on the knowledge of susceptibility profiles of the most common bacteria. We analyzed blood culture isolates from a teaching hospital for 13 years prospectively. This study examined the susceptibility profiles of 6,616 gram...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048498

    authors: Ling TK,Liu EY,Cheng AF

    更新日期:2001-01-01 00:00:00

  • Systemic infections with Candida sp. and Aspergillus sp. in immunocompromised patients with hematological malignancies: current serological and molecular diagnostic methods.

    abstract::Within recent years, novel serological and molecular methods have been developed to improve the early diagnosis of invasive fungal infections especially in patients with malignant hematological diseases being at highest risk of developing these life-threatening infections. Early diagnosis is essential for adequate the...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000007283

    authors: Buchheidt D,Skladny H,Baust C,Hehlmann R

    更新日期:2000-05-01 00:00:00

  • Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.

    abstract::Neither cefoperazone, cefotaxime, mezlocillin nor piperacillin significantly killed intraphagocytic bacteria of representative assay strains of Serratia marcescens, as determined with 55 vol% of fresh defibrinated human blood treated with 2 mg/ml of phenylbutazone, which permitted phagocytic ingestion of bacteria, but...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238173

    authors: Traub WH

    更新日期:1983-01-01 00:00:00

  • Amphotericin B dose optimization in children with malignant diseases.

    abstract::In this study, rational dosing guidelines for amphotericin B-deoxycholate (AmB) are proposed for children. AmB steady-state trough concentrations (C(ss,trough)) and plasma creatinine concentrations (C(creat)) were measured in 83 children (age: 10 months to 18 years) receiving prophylactic AmB therapy (1 mg/kg/day). Ma...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1159/000100013

    authors: Nath CE,McLachlan AJ,Shaw PJ,Coakley JC,Earl JW

    更新日期:2007-01-01 00:00:00

  • Rifaximin in the treatment of infectious diarrhea.

    abstract::Rifaximin matches the criteria for an ideal agent for the treatment of infectious diarrhea. It has excellent activity against a broad range of enteropathogens. It is nonabsorbable, which may help explain its excellent side effect profile and lack of emergence of resistance because of high stool levels that are not lik...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000081992

    authors: Ericsson CD,DuPont HL

    更新日期:2005-01-01 00:00:00

  • Differential susceptibility to etoposide in clones derived from a human ovarian cancer cell line.

    abstract:OBJECTIVES:To identify parameters/factors that may contribute to the differential sensitivity to etoposide in two clones isolated from the human ovarian carcinoma SKOV-3 cell line, which does not express p53 and is resistant to platinum-based regimens. METHODS:Differential sensitivity of the cells to etoposide was mon...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000093009

    authors: Balan KV,Sitaras NM,Dimas K,Han Z,Wyche JH,Pantazis P

    更新日期:2006-01-01 00:00:00

  • Clinical pharmacology of a new ureidopenicillin: Bay K 49999.

    abstract::A new semisynthetic ureidopenicillin (Bay K 4999) demonstrates favorably in vitro antibacterial efficacy against human-pathogenic gram-negative rods in comparison to mezlocillin and azlocillin. A comparative paramcokinetic study was done with 10 test subjects after 30 min intravenous infusion of 4.0 g of Bay K and mez...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237887

    authors: Lode H,Tomas W,Koeppe P,Wagner J

    更新日期:1980-01-01 00:00:00

  • Feasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer.

    abstract:BACKGROUND:The purpose of this study was to evaluate the feasibility and compliance of adjuvant chemotherapy of S-1 plus carboplatin for patients with completely resected non-small cell lung cancer (NSCLC) of pathological stage IB-IIIB. METHODS:S-1 was given orally at a dose of 80 mg/m²/day for 2 weeks, followed by a ...

    journal_title:Chemotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000351101

    authors: Komazaki Y,Sakashita H,Furuiye M,Fujie T,Tamaoka M,Sumi Y,Miyazaki Y,Kojima K,Jin Y,Inase N

    更新日期:2013-01-01 00:00:00

  • Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad HOC Working Group.

    abstract::Neutropenia induced by intensive chemotherapy and allogeneic bone marrow transplantation are increasingly commonly complicated by fungal infections; thus prophylaxis may be justified. The authors surveyed the literature and culled their experience - few randomized trials have been done and definitions have often been ...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000239052

    authors: Denning DW,Donnelly JP,Hellreigel KP,Ito J,Martino P,van't Wout JW

    更新日期:1992-01-01 00:00:00

  • Pharmacokinetics of fosfomycin.

    abstract::Fosfomycin, an antibiotic discovered in Spain, has a unique chemical structure and pharmacologic features that are promising for clinical therapy. It is only partially absorbed orally, with relatively low blood levels. Intramuscularly, however, absorption is complete with peak blood levels 3-5 times as high as orally,...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222040

    authors: Kirby WM

    更新日期:1977-01-01 00:00:00